Five Reasons to Buy Halocarbon Sevoflurane
Sevoflurane was first discovered as an inhalation anesthetic in the early 1970s. Since its clinical introduction in the 1990s, Sevoflurane has become the leading and most widely used inhalation anesthesia on the market. Sevoflurane is a staple in operating rooms around the world. For these reasons, it is vital to use Sevoflurane manufactured under Good Manufacturing Procedures (GMP) certifications to ensure high quality and purity. Here are the top five reasons to buy Halocarbon Sevoflurane.
Halocarbon Offers Bottled Sevoflurane to the Global Marketplace
Halocarbon has Built a Legacy of Innovation in Anesthesia
Halocarbon is a company built on firsts. As one of the world’s leading producers in specialty fluorochemicals, Halocarbon has a track record in inhalation anesthesia that spans over 30 years. Most notably, Halocarbon was the first U.S. based producer of Halothane for operating rooms. Subsequently, Halocarbon has invested in substantial capacity and capabilities for Isoflurane and Sevoflurane. As a result, Halocarbon has over 20 years’ of experience manufacturing Isoflurane and over 10 years’ of experience as a Sevoflurane manufacturer.
Halocarbon Hires H. Carl Walther as Technical Services Manager
31-year veteran spent 18 years with Krytox™ Performance Lubricants
ATLANTA – August 2, 2016 – Halocarbon Products Corporation, a leading worldwide producer of specialty fluorochemicals, inert lubricants and inhalation anesthetics, today announced that H. Carl Walther has joined the company as Manager, Technical Services/Support.
Walther brings 31 years of technical service, R&D, customer training and production experience to the position. He comes to Halocarbon after 18 years with DuPont™ Krytox® Performance Lubricants – the Krytox™ business was recently spun off in the Chemours group of businesses last year.
Halocarbon Hires Industry Veteran for Sales and Marketing
ATLANTA – May 29, 2016 – Halocarbon Products Corporation, a leading worldwide producer of specialty fluorochemicals, inhalation anesthetics, and inert lubricants, today announced the hiring of industry veteran: Dr. Siddhartha Shenoy as Director of Strategic Marketing.
“Sidd Shenoy is joining Halocarbon during an exciting time of innovation and product development and will be instrumental in supporting Halocarbon’s growth,” said David Bacon, CEO of Halocarbon. “Sidd is a proven leader in organic chemistry with the ability to cultivate strategic direction for innovative products for commercialization. With this new addition, Halocarbon is well positioned to accelerate growth and to expand our diverse line of fluorochemical solutions to better serve our customers.”
Halocarbon Products Corporation Officially Moves Headquarters to Atlanta
ATLANTA – December 15, 2015 – Halocarbon Products Corporation, a leading worldwide producer of specialty fluorochemicals, non-flammable oils, greases and waxes, and inhalation anesthetics, today announced that the company will be officially moving its headquarters to Atlanta, Georgia, effective December 31, 2015.
“The relocation makes access to our company’s manufacturing site in North Augusta, South Carolina, much faster and easier while allowing Halocarbon to tap into a large pool of innovative, collaborative, and tech-savvy talent,” said David Bacon, CEO of Halocarbon. “The look and feel of our new headquarters reflects the evolving personality of our company: progressive, forward-looking and highly accessible. We are very excited to begin the next phase of Halocarbon’s growth here in Atlanta.”
Halocarbon Appoints David Bacon New Chief Executive Officer | Halocarbon
RIVER EDGE, N.J. – April 15, 2015 – Halocarbon Products Corporation, a leading worldwide producer of specialty fluorochemicals and inhalation anesthetics, today announced that David Bacon will be joining the company as its new chief executive officer, effective April 28, 2015.
Bacon, 46, joins Halocarbon with more than 24 years of experience in market analysis and driving innovation. As Halocarbon’s new CEO, Bacon’s top priorities will be leading the next phase of the company’s growth and product innovation.